Orexo AB (publ) (STO:ORX)
Sweden · Delayed Price · Currency is SEK 15.14
-0.26 (-1.69%)
Sep 4, 2026, 5:29 PM CET
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 528.71 million as of September 4, 2026. Its market cap has decreased by -23.77% in one year.
Market Cap
528.71M
Enterprise Value
261.71M
Revenue
16.60M
Ranking
n/a
PE Ratio
1.15
Stock Price
15.14
ChartMarket Cap Chart
Since November 9, 2005, Orexo AB's market cap has decreased from 861.50M to 528.71M, a decrease of -38.63%. That is a compound annual growth rate of -2.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 528.71M | -49.09% |
| Dec 30, 2025 | 1.04B | 72.00% |
| Dec 30, 2024 | 603.84M | 13.47% |
| Dec 29, 2023 | 532.14M | -17.90% |
| Dec 30, 2022 | 648.17M | -45.27% |
| Dec 30, 2021 | 1.18B | -30.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.36B |
| Nanexa AB | 1.14B |
| Dicot Pharma AB | 793.64M |
| EQL Pharma AB | 761.86M |
| Cinclus Pharma Holding AB | 630.12M |
| Moberg Pharma AB | 531.26M |
| Enzymatica AB | 447.85M |
| Klaria Pharma Holding AB (publ.) | 156.19M |